ArticleJournal of bone and mineral metabolism2022

Real-world persistence of twice-weekly teriparatide and factors associated with the discontinuation in patients with osteoporosis.

Ryo Fujita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.